Posts Tagged ‘type 2 diabetes’

Yogurt Gets an Ad Claim for Preventing Diabetes

March 3, 2024 — Five years ago, Danone asked FDA if it would be OK to say eating yogurt might prevent type 2 diabetes. Or to be precise, “eating yogurt regularly may reduce the risk of type 2 diabetes.” Friday, FDA told Danone, yep, we’re cool with that. Or, in the language of the agency: “FDA concludes that the […]

The Overselling of Diet and Exercise for Diabetes Remission

January 27, 2024 — Zeal is thrilling. “The solution is at hand” for type 2 diabetes, says Professor Roy Taylor. “If a person has T2DM, they have become too heavy for their own body.” Losing weight with his very low calorie diet will put that diabetes into remission, he says. “A simple bottom line.” Except that a new study […]

Food as Medicine: Great Program, but Lacking a Medical Benefit

December 27, 2023 — Food as medicine programs can yield a fantastic medical benefit, say the promoters of this currently trendy concept in nutrition policy. If implemented broadly, they “would save lives and billions of dollars.” That’s the word from Tufts, where Dariush Mozaffarian is selling this concept with great enthusiasm. The whole idea behind these claims is that […]

Loose Takes on a Study of Red Meat and Type 2 Diabetes

October 25, 2023 — It’s a popular cause. Red meat production is a problem for the climate. Add that to ethical concerns some people have about consuming meat, and the push to reduce red meat consumption makes total sense. But when people start spinning misleading narratives about observational research and using them to promote this otherwise worthy idea, they’re […]

Did Tirzepatide Steal the Show at EASD?

October 6, 2023 — At EASD this week, it was quite a showing for tirzepatide. Sold under the brand name Mounjaro, it’s already available for treating diabetes and it’s awaiting approval for treating obesity. Based on the research presented at EASD this week, semaglutide might be looking a little like old news. For tirzepatide, a total of 11 presentations […]

A Fierce Debate at EASD 2023 About Diabetes Remission

October 5, 2023 — Two professors yesterday at the EASD meeting engaged in a fierce and collegial debate about the feasibility of lasting remission in type 2 diabetes with very low calorie diets. Professor Kamlesh Khunti brought a polished presentation of objective data. He was unequivocal. Is lasting remission feasible in a real world setting? “It’s a definite no […]

The Effect of Hookworms on Metabolic Health

August 29, 2023 — Bet you never saw this one coming. We did not. But a new RCT published in Nature Communications suggests that hookworms might have benefits for the metabolic health of people with insulin resistance that puts them at risk for type 2 diabetes. This was a phase 1 study with the primary aim of confirming the […]

ADA2023: An Amazing 3-in-1 Obesity Medicine

June 27, 2023 — The last of four big days at ADA2023 brought us astonishing results from three studies of a new obesity medicine, retatrutide. This is the first 3-in-1 metabolic receptor agonist to advance this far in clinical trials as a medicine for obesity or diabetes. Researchers presented phase 2 results for obesity, diabetes, and NAFLD – three […]

ADA2023: A Golden Age of Obesity Medicine?

June 26, 2023 — “We may be on the cusp of an era of astonishing innovation – the limits of which aren’t even clear yet,” writes David Wallace-Wells in the New York Times. Among other breakthroughs, he cites the transformation in care that semaglutide and tirzepatide are bringing for the most prevalent chronic disease in the world – obesity. […]

Headline Fantasies: Coffee and Obesity

March 17, 2023 — “Coffee could slash obesity,” says the New York Post. Now you might think that cynical folks at the Post just make this stuff up because it’s so obviously false. But in fact, they have help from PR by the BMJ, and they’re not alone. The BMJ managed to induce quite a few news outlets last […]